Location: Marriott Hyderabad - Hyderabad, India

This conference has been expanded and enhanced to showcase how international and Indian companies are actively incorporating India as part of a global strategy to accelerate drug discovery, become more efficient in clinical development or to strategically position themselves to take advantage of India's rapidly expanding pharmaceutical marketplace. Two conference tracks: "Discovery to Innovation" and "Clinical Trials in India" will feature multiple case studies from Western companies who are actively leveraging the "India Advantage" through on-the-ground R&D activities in India or through partners and CROs in India. Speakers will share their day to day practical experiences, challenges, and lessons learned. In addition, top Indian pharma and biotech companies like Ranbaxy, Dr. Reddy's, Biocon, Nicholas Piramal, Wockhardt, Torrent, Avesthagen, Dabur and others have confirmed as speakers to share their companies' R&D strategies and partnership objectives as they expand their R&D capabilities and global initiatives.

For more information Click Here.